Works matching IS 00912700 AND DT 2016 AND VI 56 AND IP 3

Results: 15

A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 316, doi. 10.1002/jcph.590

By:

Csonka, Denes;
Hazell, Katharine;
Waldron, Edward;
Lorenzo, Sebastien;
Duval, Vincent;
Trandafir, Lucia;
Kobalava, Zhanna D.

Publication type:

Article

Pharmacokinetics of high-dose intravenous melatonin in humans.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 324, doi. 10.1002/jcph.592

By:

Andersen, Lars P. H.;
Werner, Mads U.;
Rosenkilde, Mette M.;
Fenger, Andreas Q.;
Petersen, Marian C.;
Rosenberg, Jacob;
Gögenur, Ismail

Publication type:

Article

Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 355, doi. 10.1002/jcph.595

By:

Mendonza, Anisha;
Hanna, Imad;
Meyers, Dan;
Koo, Phillip;
Neelakantham, Srikanth;
Zhu, Bing;
Majumdar, Tapan;
Rebello, Sam;
Sunkara, Gangadhar;
Chen, Jin

Publication type:

Article

Pilot evaluation of the population pharmacokinetics of bumetanide in term newborn infants with seizures.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 284, doi. 10.1002/jcph.596

By:

Jullien, Vincent;
Pressler, Ronit M.;
Boylan, Geraldine;
Blennow, Mats;
Marlow, Neil;
Chiron, Catherine;
Pons, Gerard

Publication type:

Article

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 330, doi. 10.1002/jcph.597

By:

Ravenstijn, Paulien;
Remmerie, Bart;
Savitz, Adam;
Samtani, Mahesh N.;
Nuamah, Isaac;
Chang, Cheng‐Tao;
De Meulder, Marc;
Hough, David;
Gopal, Srihari

Publication type:

Article

Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 298, doi. 10.1002/jcph.598

By:

Estepp, Jeremie H.;
Melloni, Chiara;
Thornburg, Courtney D.;
Wiczling, Paweł;
Rogers, Zora;
Rothman, Jennifer A.;
Green, Nancy S.;
Liem, Robert;
Brandow, Amanda M.;
Crary, Shelley E.;
Howard, Thomas H.;
Morris, Maurine H.;
Lewandowski, Andrew;
Garg, Uttam;
Jusko, William J.;
Neville, Kathleen A.

Publication type:

Article

A personal perspective of orphan drug development for rare diseases: A golden opportunity or an unsustainable future?

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 257, doi. 10.1002/jcph.599

By:

Oo, Charles;
Rusch, Lorraine M.

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 251, doi. 10.1002/jcph.709
Publication type:: Article

Addressing potential role of magnesium dyshomeostasis to improve treatment efficacy for epilepsy: A reexamination of the literature.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 260, doi. 10.1002/jcph.626

By:

Osborn, Katie E.;
Shytle, R. Douglas;
Frontera, Alfred T.;
Soble, Jason R.;
Schoenberg, Mike R.

Publication type:

Article

Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 266, doi. 10.1002/jcph.585

By:

Upreti, Vijay V.;
Wahlstrom, Jan L.

Publication type:

Article

Genetic variation of CYP3A5 influences paclitaxel/carboplatin-induced toxicity in Chinese epithelial ovarian cancer patients.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 349, doi. 10.1002/jcph.587

By:

Hu, Lei;
Lv, Qiao‐Li;
Guo, Ying;
Cheng, Lin;
Wu, Na‐Yiyuan;
Qin, Chong‐Zhen;
Zhou, Hong‐Hao

Publication type:

Article

Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: Validation of clinical trial simulations.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 291, doi. 10.1002/jcph.601

By:

Nehus, Edward J.;
Mizuno, Tomoyuki;
Cox, Shareen;
Goldstein, Stuart L.;
Vinks, Alexander A.

Publication type:

Article

Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetes.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 340, doi. 10.1002/jcph.602

By:

Alskär, Oskar;
Bagger, Jonatan I.;
Røge, Rikke M.;
Knop, Filip K.;
Karlsson, Mats O.;
Vilsbøll, Tina;
Kjellsson, Maria C.

Publication type:

Article

Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 365, doi. 10.1002/jcph.603

By:

Tolbert, Dwain;
Bekersky, Ihor;
Chu, Hui‐May;
Ette, Ene I.

Publication type:

Article

Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 307, doi. 10.1002/jcph.600

By:

Kees, Martin G.;
Minichmayr, Iris K.;
Moritz, Stefan;
Beck, Stefanie;
Wicha, Sebastian G.;
Kees, Frieder;
Kloft, Charlotte;
Steinke, Thomas

Publication type:

Article